Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History includes a new revision entry v3.5.0 and removes the previous revision v3.4.3.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedAdded a new site revision note (v3.4.2) and removed an old operational notice about government funding; these are administrative updates and do not alter study records or user workflows. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check56 days agoChange DetectedThe page adds a government funding lapse notice with links about operating status and shows a new site revision tag (v3.4.1), while the previous revision tag (v3.4.0) is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check63 days agoChange DetectedThe page adds a glossary toggle, color-coded indicators for additions and deletions, and visible revision metadata (e.g., Revision: v3.4.0).SummaryDifference1.0%

- Check77 days agoChange DetectedThe study record versions now show Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.